Literature DB >> 20419482

Rapidly progressing malignant insulinoma presented with multiple liver metastases: a case report.

Askin Erdogan1, Erdogan Askin, Fatih Kose, Kose Fatih, Hampar Akkaya, Akkaya Hampar, Neslihan Bascil Tutuncu, Neslihan Bascil Tutuncu, Ozgur Ozyilkan, Ozyilkan Ozgur.   

Abstract

INTRODUCTION: A 51-year-old female was admitted to emergency unit with sudden loss of consciousness. Her blood glucose level from fingertip was 33 mg/dl, and insulin level was 55 (normal range, 4-17 IU). Abdominal ultrasonography revealed pancreatic mass with diffuse liver metastases. Biopsy of liver metastases showed differentiated neuroendocrine carcinoma. METHODS AND
RESULTS: Diazoxide and chemotherapy stabilized her glucose level for more than 4 months. However, the disease showed progression, and death occurred 8 months later.
CONCLUSION: In conclusion, this case may suggest that biologic behavior may differ from histological behavior in insulinoma and platin-based systemic chemotherapy may provide some benefit in patients those who had diazoxide- and octreotide-resistant tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419482     DOI: 10.1007/s12029-010-9157-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  6 in total

1.  Metastatic neuroendocrine hepatic tumors: resection improves survival.

Authors:  Sandeepa Musunuru; Herbert Chen; Sharad Rajpal; Nicholas Stephani; John C McDermott; Kyle Holen; Layton F Rikkers; Sharon M Weber
Journal:  Arch Surg       Date:  2006-10

2.  Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

Authors:  Sanjay Gupta; Marcella M Johnson; Ravi Murthy; Kamran Ahrar; Michael J Wallace; David C Madoff; Stephen E McRae; Marshall E Hicks; Sujaya Rao; Jean-Nicolas Vauthey; Jaffer A Ajani; James C Yao
Journal:  Cancer       Date:  2005-10-15       Impact factor: 6.860

3.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

Authors:  F J Service; M M McMahon; P C O'Brien; D J Ballard
Journal:  Mayo Clin Proc       Date:  1991-07       Impact factor: 7.616

Review 4.  The surgical and systemic management of neuroendocrine tumors of the pancreas.

Authors:  Gerard J Abood; Aileen Go; Deepak Malhotra; Margo Shoup
Journal:  Surg Clin North Am       Date:  2009-02       Impact factor: 2.741

5.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

Review 6.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

  6 in total
  1 in total

1.  Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia.

Authors:  Marco Ciacciarelli; Gianluca Caruso; Marco Rengo; Piero Maceroni; Carmen Misurale; Eleonora D'Armiento; Alessandro Polidoro; Cristina Napoli; Alberto Lombardini; Umberto Ceratti; Ruben Manuel Luciano Colunga Biancatelli; Leonardo Calvosa; Romina Milanese; Sonia Ferri; Teresa Massaro; Andrea Lorusso; Veronica Sorrentino; Vincenzo Petrozza; Luigi Iuliano
Journal:  Case Rep Endocrinol       Date:  2020-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.